Paliperidone and Risperidone interaction

Paliperidone and Risperidone: both prescribing labels flag this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.

Major

Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.

What the FDA labels say

From the Paliperidone (Erzofri extended-release) label · effective 2026-03-09

Major

ERZOFRI is contraindicated in patients with a known hypersensitivity to either paliperidone or risperidone, or to any of the excipients in the ERZOFRI formulation.

Contraindicationsnames RisperidoneView label on DailyMed
Major

Hypersensitivity reactions, including anaphylactic reactions and angioedema, have been reported in patients treated with risperidone and in patients treated with paliperidone [see Adverse Reactions (6.1 , 6.2) ] .

Contraindicationsnames RisperidoneView label on DailyMed
Major

Known hypersensitivity to paliperidone, risperidone, or to any excipients in ERZOFRI.

Contraindicationsnames RisperidoneView label on DailyMed
Major

Cerebrovascular Adverse Reactions, Including Stroke, in Elderly Patients with Dementia-Related Psychosis In placebo-controlled trials with risperidone, aripiprazole, and olanzapine in elderly subjects with dementia, there was a higher incidence of cerebrovascular adverse reactions (cerebrovascular accidents and transient ischemic attacks) including fatalities…

Warnings and precautionsnames RisperidoneView label on DailyMed
Moderate

An increase in the incidence of pituitary gland, mammary gland, and pancreatic islet cell neoplasia (mammary adenocarcinomas, pituitary and pancreatic adenomas) was observed in the risperidone carcinogenicity studies conducted in mice and rats [see Nonclinical Toxicology (13.1) ] .

Warnings and precautionsnames RisperidoneView label on DailyMed

From the Risperidone (RISPERDAL CONSTA) label · effective 2025-11-05

Major

RISPERDAL CONSTA is contraindicated in patients with a known hypersensitivity to either risperidone or paliperidone, or to any of the excipients in the RISPERDAL CONSTA formulation.

Contraindicationsnames PaliperidoneView label on DailyMed
Major

Hypersensitivity reactions, including anaphylactic reactions and angioedema, have been reported in patients treated with risperidone and in patients treated with paliperidone.

Contraindicationsnames PaliperidoneView label on DailyMed
Major

Paliperidone is a metabolite of risperidone.

Contraindicationsnames PaliperidoneView label on DailyMed
Major

Known hypersensitivity to risperidone, paliperidone, or to any excipients in RISPERDAL CONSTA.

Contraindicationsnames PaliperidoneView label on DailyMed
Moderate

RISPERDAL CONSTA and other antipsychotic drugs should be used cautiously in patients at risk for aspiration pneumonia. [see also Boxed Warning and Warnings and Precautions (5.1) ] 5.13 Priapism Priapism has been reported during postmarketing surveillance [see Adverse Reactions (6.2) ] .

Warnings and precautionsby drug classView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.